Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors
Abstract Background Testicular cancer is the most common male neoplasm occurring in men between the ages of 20 and 34. Although germ-line testicular tumors respond favorably to current standard of care, testicular stromal cell (TSC) tumors derived from Sertoli cells or Leydig cells often fail to res...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
BMJ Publishing Group
2017-04-01
|
| Collection: | Journal for ImmunoTherapy of Cancer |
| Sujets: | |
| Accès en ligne: | http://link.springer.com/article/10.1186/s40425-017-0237-2 |